(R)-3-Methyl-7-(5-methyl-2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)-2-((6-methylpyridin-2-yl)methyl)-3,4-dihydropyrrolo[1,2-a]pyrazin-1(2H)-one

ID: ALA4071576

PubChem CID: 122604287

Max Phase: Preclinical

Molecular Formula: C24H26N8O

Molecular Weight: 442.53

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cccc(CN2C(=O)c3cc(-c4nc(Nc5ccnn5C)ncc4C)cn3C[C@H]2C)n1

Standard InChI:  InChI=1S/C24H26N8O/c1-15-11-25-24(28-21-8-9-26-30(21)4)29-22(15)18-10-20-23(33)32(17(3)12-31(20)13-18)14-19-7-5-6-16(2)27-19/h5-11,13,17H,12,14H2,1-4H3,(H,25,28,29)/t17-/m1/s1

Standard InChI Key:  VKGZTIYOOVDXAF-QGZVFWFLSA-N

Molfile:  

     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   15.4517  -10.5524    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1669  -10.9645    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4517   -9.7281    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.8820  -10.5524    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.8820   -9.7281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1669   -9.3160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6677  -10.8093    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1834  -10.1403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6677   -9.4714    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1669  -11.7887    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.5930  -10.9645    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3082  -10.5524    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3082   -9.7281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0234   -9.3160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7345   -9.7281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7345  -10.5524    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0234  -10.9645    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.4496  -10.9645    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1229   -9.4251    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9471   -9.4251    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.3592  -10.1403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9471  -10.8555    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1229  -10.8555    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7108  -10.1403    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.7108   -8.7141    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.4023   -9.3789    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.6184   -9.1262    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.6184   -8.3020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4023   -8.0451    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8865   -8.7141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6592  -10.1628    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3592  -11.5665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5930   -9.3160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  3  6  1  0
  7  8  1  0
  8  9  2  0
  3  9  1  0
  1  7  2  0
  2 10  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 12 17  2  0
 16 18  1  0
 11 12  1  0
  4 11  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 19 24  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 26 30  1  0
 26 31  1  0
 25 30  1  0
 19 25  1  0
 22 32  1  0
  8 21  1  0
  5 33  1  1
M  END

Alternative Forms

  1. Parent:

    ALA4071576

    ---

Associated Targets(Human)

MAP2K1 Tclin Dual specificity mitogen-activated protein kinase kinase 1 (4127 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK1 Tchem MAP kinase ERK2 (25055 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver (3974 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (7708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Calu-6 (398 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK3 Tchem Mitogen-activated protein kinase; ERK1/ERK2 (651 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (10718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Canis familiaris (36305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 442.53Molecular Weight (Monoisotopic): 442.2230AlogP: 3.48#Rotatable Bonds: 5
Polar Surface Area: 93.76Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 12.78CX Basic pKa: 4.85CX LogP: 2.72CX LogD: 2.72
Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.51Np Likeness Score: -1.50

References

1. Ward RA, Bethel P, Cook C, Davies E, Debreczeni JE, Fairley G, Feron L, Flemington V, Graham MA, Greenwood R, Griffin N, Hanson L, Hopcroft P, Howard TD, Hudson J, James M, Jones CD, Jones CR, Lamont S, Lewis R, Lindsay N, Roberts K, Simpson I, St-Gallay S, Swallow S, Tang J, Tonge M, Wang Z, Zhai B..  (2017)  Structure-Guided Discovery of Potent and Selective Inhibitors of ERK1/2 from a Modestly Active and Promiscuous Chemical Start Point.,  60  (8): [PMID:28376306] [10.1021/acs.jmedchem.7b00267]
2. Ward RA, Anderton MJ, Bethel P, Breed J, Cook C, Davies EJ, Dobson A, Dong Z, Fairley G, Farrington P, Feron L, Flemington V, Gibbons FD, Graham MA, Greenwood R, Hanson L, Hopcroft P, Howells R, Hudson J, James M, Jones CD, Jones CR, Li Y, Lamont S, Lewis R, Lindsay N, McCabe J, McGuire T, Rawlins P, Roberts K, Sandin L, Simpson I, Swallow S, Tang J, Tomkinson G, Tonge M, Wang Z, Zhai B..  (2019)  Discovery of a Potent and Selective Oral Inhibitor of ERK1/2 (AZD0364) That Is Efficacious in Both Monotherapy and Combination Therapy in Models of Nonsmall Cell Lung Cancer (NSCLC).,  62  (24): [PMID:31710489] [10.1021/acs.jmedchem.9b01295]

Source